Table 2.

Viability status of Prohemistomum vivax encysted metacercariae (EMC) after praziquantel treatment.

Group	Treatment	Live EMC (%) (Mean ± SD)	Degenerated EMC (%) (Mean ± SD)	Dead EMC (%) (Mean ± SD)
G1	Control (0 mg/L)	95.6 ± 2.4	3.2 ± 1.1	1.2 ± 0.6
G2	0.5 mg/L (single dose)	78.4 ± 4.3	16.7 ± 3.2	4.9 ± 1.4
G3	2 mg/L (single dose)	62.1 ± 5.1	28.6 ± 4.4	9.3 ± 2.1
G4	3 mg/L (single dose)	45.7 ± 4.6	39.2 ± 3.8	15.1 ± 2.7
G5	0.5 mg/L (double dose)	56.3 ± 4.8	31.5 ± 4.1	12.2 ± 2.5
G6	2 mg/L (double dose)	28.9 ± 3.7	47.6 ± 4.5	23.5 ± 3.1
G7	3 mg/L (double dose)	12.4 ± 2.9